NCT06238362
TheraPAP Equivalence Crossover Study
Randomized Crossover Study to Compare Effectiveness of a Device Providing Pressure Drops During Inspiration (TPAP) to Continuous Positive Airway Pressure (CPAP) in Obstructive Sleep Apnea (OSA)
SleepRes Inc.·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Obstructive Sleep Apnea
- Drug/Device/Intervention
- TPAP
- Study type
- Interventional
- Intervention type
- other
Sponsor & location
- Primary sponsor
- SleepRes Inc.
- Location
- Clarksville, United States of America
Timeline & enrollment
- Phase
- N/A
- Start date
- Mar 07, 2024
- End date
- Jul 30, 2024
- Enrollment
- 150 participants
Primary outcome
Apnea/Hypopnea Index
Summary
The present study, TheraEquivalence, is a Phase 2 crossover study designed to examine the
 efficacy and safety of TheraPAP (TPAP) vs. CPAP alone in the treatment of OSA.
ICD-10 classifications
Sleep apnoeaSleep disordersSleep disorder, unspecifiedPrimary sleep apnoea of newbornNonorganic sleep disorders
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06238362
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06238362 through Pure Global AI's free database. This phase not specified trial is sponsored by SleepRes Inc. and is currently Recruiting. The study focuses on Obstructive Sleep Apnea. Target enrollment is 150 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.